After hours:
Chart Events
Performance Outlook
| Previous Close | 95.93 |
| Open | 94.99 |
| Bid | 93.72 x 900 |
| Ask | 151.63 x 900 |
| Day's Range | 93.84 - 96.31 |
| 52 Week Range | 71.09 - 155.51 |
| Volume | |
| Avg. Volume | 402,798 |
| Market Cap | 2.863B |
| Beta (5Y Monthly) | 1.34 |
| PE Ratio (TTM) | 44.72 |
| EPS (TTM) | 2.10 |
| Earnings Date | Feb 02, 2023 |
| Forward Dividend & Yield | 0.80 (0.83%) |
| Ex-Dividend Date | Dec 15, 2022 |
| 1y Target Est | 100.50 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for CNMD
Related Research
- CONMED CorporationCNMD: Lowering target price to $100.00CONMED CORP has an Investment Rating of HOLD; a target price of $100.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.RatingFair ValueEconomic Moat5 days agoArgus Research
- Insider Monkey
15 Largest Orthopedic Companies in the World
In this article, we will take a look at the 15 largest orthopedic companies in the world. If you want to see more companies in this selection, go to the 5 Largest Orthopedic Companies in the World. The orthopedic industry has staged a comeback in the last two years following a dismal 2020 due to […]
- Business Wire
CONMED Corporation to Announce Fourth Quarter 2022 Financial Results on February 2, 2023
LARGO, Fla., January 09, 2023--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, February 2, 2023. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
- Zacks
Here's Why You Should Retain CONMED (CNMD) Stock for Now
Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.
